Steatotic liver disease as a new nomenclature for NAFLD from the perspectives of the MENA region: One size fits all this time [0.03%]
从中东和北非地区视角看，将非酒精性脂肪肝病命名为“胆脂样肝病”：这一次放之四海而皆准
Mohamed El-Kassas,Khalid Alswat;Steatotic Liver Disease Study Foundation in Middle East and North Africa (SLMENA)
Mohamed El-Kassas
Sex differences in prevalence and prognosis of steatotic liver disease phenotypes: Biological sex matters [0.03%]
性别差异在肝脂肪变性表型流行率和预后方面的影响：生理性别很重要
Hongwei Ji,Susan Cheng;Heart-Liver Axis Research Collaboration
Hongwei Ji
A fetal wound healing program after intrauterine bile duct injury may contribute to biliary atresia [0.03%]
宫内胆管损伤后的胎儿伤口愈合程序可能促成了婴儿肝炎综合征中的胆道闭锁
Iris E M de Jong,Mallory L Hunt,Dongning Chen et al.
Iris E M de Jong et al.
Background & aims: Biliary atresia (BA) is an obstructive cholangiopathy that initially affects the extrahepatic bile ducts (EHBDs) of neonates. The etiology is uncertain, but evidence points to a prenatal cause. Fetal ti...
Reply to: "Defining severe NAFLD based on ICD codes in large cohorts: Balancing feasibility and limitations" [0.03%]
对“基于ICD编码在大样本中定义严重非酒精性脂肪肝的可行性与局限性”的回复
Fanny Petermann-Rocha,Frederick K Ho,Jill P Pell
Fanny Petermann-Rocha
Combined inhibition of surface CD51 and γ-secretase-mediated CD51 cleavage improves therapeutic efficacy in experimental metastatic hepatocellular carcinoma [0.03%]
联合抑制表面CD51和γ-分泌酶介导的CD51切割可提高实验性肝细胞癌转移治疗疗效
Jianye Cai,Jiancheng Wang,Chenhao Jiang et al.
Jianye Cai et al.
Background & aims: Integrin αv (ITGAV, CD51) is regarded as a key component in multiple stages of tumor progression. However, the clinical failure of cilengitide, a specific inhibitor targeting surface CD51, suggests the...
Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study [0.03%]
非酒精性脂肪肝病进展及长期预后：全国配对肝活检队列研究
Tracey G Simon,Bjorn Roelstraete,Hannes Hagström et al.
Tracey G Simon et al.
Background & aims: More data are needed regarding the long-term impact of the histological progression of non-alcoholic fatty liver disease (NAFLD) on long-term outcomes, including end-stage liver disease (ESLD) and morta...
Cyril Neftel,Khalil Zaman,Haithem Chtioui et al.
Cyril Neftel et al.
Immunomodulatory effects of tenofovir disoproxil fumarate and entecavir in treating HBV infection [0.03%]
替诺福韦酯和恩替卡韦治疗HBV感染的免疫调节作用
Xueping Yu,Jianfei Long,Yiran Xie et al.
Xueping Yu et al.
IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies [0.03%]
IgG4相关性胆管炎-一种纤维化及恶性胆汁淤积症的假象诊断
Remco Kersten,David C Trampert,Toni Herta et al.
Remco Kersten et al.
IgG4-related cholangitis (IRC) is the major hepatobiliary manifestation of IgG4-related disease (IgG4-RD), a systemic fibroinflammatory disorder. The pathogenesis of IgG4-RD and IRC is currently viewed as multifactorial, as there is evidenc...
Partha Pratim Ray
Partha Pratim Ray